HNR1.SW Hannover Rück SE (SIX) Market Closed: CHF 219 oversold bounce on 18 Feb 2026

HNR1.SW stock closed up 37.74% at CHF 219.00 on 18 Feb 2026, marking a sharp oversold bounce as the Swiss market (SIX) closed. The move followed a prior slide that left the share price trading near value multiples. Volume remained light at 25 shares, but the price gap reflects renewed buying interest. We review fundamentals, technical setup, Meyka AI grade and near-term targets for Hannover Rück SE to frame an oversold-bounce trade idea.

HNR1.SW stock: Price action and immediate drivers

Hannover Rück SE (HNR1.SW) closed at CHF 219.00, up CHF 60.00 from the prior close of CHF 159.00. The intraday spread was flat, with day low and high both at CHF 219.00, showing a low-liquidity gap close. This price jump aligns with short-covering and repositioning after weakness, a classic oversold bounce in the insurance sector.

HNR1.SW stock: Fundamentals, valuation and income metrics

Hannover Rück reports EPS 19.03 and a trailing PE 11.51, suggesting value relative to Swiss financial peers. Market cap stands near CHF 26.41B and dividend per share is CHF 9.00, with dividend yield about 3.63%. Key ratios show robust solvency and a debt to equity 0.35, supporting dividend stability and reinsurance cash flows.

HNR1.SW stock: Technical view and oversold bounce setup

Price action shows a sharp rebound off recent lows, characteristic of an oversold bounce trade. On low volume the stock jumped, indicating short-covering more than fresh accumulation. Traders should watch follow-through above CHF 225.00 to confirm momentum and monitor average volume of 24,790 for durable moves.

HNR1.SW stock: Meyka AI grade and forecast model

Meyka AI rates HNR1.SW with a score out of 100: 75.17 (Grade B+, Suggestion: BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst input. Meyka AI’s forecast model projects a 12-month target of CHF 173.34, with monthly and quarterly short-term projections at CHF 219.00.

HNR1.SW stock: Risks, catalysts and sector context

Primary risks include catastrophe losses, reserve volatility and global economic slowdown that affects premiums. Catalysts are better-than-expected quarterly HNR1.SW earnings and firming reinsurer pricing. Financial Services sector trends show modest YTD weakness, so Hannover Rück’s value metrics may attract yield-focused investors.

HNR1.SW stock: Tactical trading and analyst-style targets

For an oversold-bounce trade consider a staged entry near CHF 210.00 with stop below CHF 195.00. Short-term price target for momentum traders is CHF 240.00, while conservative investors can use CHF 200.00 as an initial price target. Always size positions to volatility and confirm moves on rising volume.

Final Thoughts

HNR1.SW stock staged a clear oversold bounce, closing at CHF 219.00 on 18 Feb 2026 with a 37.74% jump from CHF 159.00. Fundamentals remain supportive: EPS 19.03, PE 11.51, dividend per share CHF 9.00, and manageable debt. Meyka AI’s forecast model projects a 12-month level of CHF 173.34, implying a model-based downside of -20.86% from today’s price. That projection contrasts with short-term bullish momentum, so the opportunity suits tactical traders who want to capture a bounce while managing tail risk. Our Meyka AI grade (B+, score 75.17) reflects strong cash flow metrics and sector positioning, but also flags valuation tension versus the modelled 12-month view. Monitor upcoming HNR1.SW earnings on 2026-03-12, volume trends and reinsurance pricing. For investors, use disciplined entries, clear stops and expect volatility as the market reconciles short-term momentum with model forecasts. Sources: Hannover Rück site and our Meyka stock page Meyka HNR1.SW. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.